SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-24-007532
Filing Date
2024-06-07
Accepted
2024-06-07 17:11:51
Documents
19
Period of Report
2024-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K drma_8k.htm   iXBRL 8-K 36527
2 ATM AGREEMENT drma_ex11.htm EX-1.1 210608
3 OPINION OF LOWENSTEIN drma_ex51.htm EX-5.1 9866
9 drma_ex51img3.jpg GRAPHIC 5054
10 drma_ex51img4.jpg GRAPHIC 7503
  Complete submission text file 0001654954-24-007532.txt   475473

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA drma-20240607.xsd EX-101.SCH 6154
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE drma-20240607_lab.xml EX-101.LAB 16881
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drma-20240607_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drma-20240607_pre.xml EX-101.PRE 12339
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drma-20240607_def.xml EX-101.DEF 4200
22 EXTRACTED XBRL INSTANCE DOCUMENT drma_8k_htm.xml XML 5817
Mailing Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #322 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40739 | Film No.: 241030619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)